Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
CALL
Syndax Pharmaceuticals
SNDX
$1.77B
| $2.33M | ﹤0.01% |
160,700
+159,300
| +11,379% | +$3.01M |
|
4852
PUT
Ryder
R
$10.1B
| $2.33M | ﹤0.01% |
21,800
-4,300
| -16% | -$418K |
|
|
NWLI
4853
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $2.33M | ﹤0.01% |
+5,329
| New | +$2.34M |
|
4854
CALL
Hess Midstream
HESM
$5.2B
| $2.33M | ﹤0.01% |
80,000
-31,200
| -28% | -$941K |
|
4855
PUT
ProShares Ultra Semiconductors
USD
$2.96B
| $2.33M | ﹤0.01% |
242,000
+99,200
| +69% | +$1.05M |
|
4856
Strive Emerging Markets ex-China ETF
STXE
$144M
| $2.33M | ﹤0.01% |
93,182
+35,801
| +62% | +$939K |
|
4857
Acco Brands
ACCO
$401M
| $2.33M | ﹤0.01% |
405,759
-658,541
| -62% | -$3.67M |
|
|
CMRX
4858
DELISTED
Chimerix, Inc.
CMRX
| $2.33M | ﹤0.01% |
2,426,526
-350,269
| -13% | -$381K |
|
4859
Pacer Trendpilot 100 ETF
PTNQ
$1.27B
| $2.33M | ﹤0.01% |
37,883
+30,835
| +438% | +$1.92M |
|
4860
abrdn Physical Silver Shares ETF
SIVR
$4.49B
| $2.33M | ﹤0.01% |
109,453
+83,450
| +321% | +$1.89M |
|
4861
PUT
Clean Harbors
CLH
$17B
| $2.33M | ﹤0.01% |
13,900
+5,200
| +60% | +$877K |
|
4862
Genesis Energy
GEL
$1.93B
| $2.32M | ﹤0.01% |
225,236
-172,796
| -43% | -$1.7M |
|
|
CSA
4863
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
| $2.32M | ﹤0.01% |
+39,683
| New | +$2.44M |
|
4864
Alamo Group
ALG
$2.01B
| $2.32M | ﹤0.01% |
13,441
-10,206
| -43% | -$1.83M |
|
4865
PUT
Macerich
MAC
$7.01B
| $2.32M | ﹤0.01% |
212,900
-59,200
| -22% | -$706K |
|
|
TWNK
4866
PUT
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $2.32M | ﹤0.01% |
69,700
+38,600
| +124% | +$1.03M |
|
|
SAGE
4867
CALL
DELISTED
Sage Therapeutics
SAGE
| $2.32M | ﹤0.01% |
112,800
+71,800
| +175% | +$2.07M |
|
4868
CALL
The Greenbrier Companies
GBX
$1.41B
| $2.32M | ﹤0.01% |
58,000
-19,500
| -25% | -$837K |
|
4869
CALL
Avery Dennison
AVY
$13.6B
| $2.32M | ﹤0.01% |
12,700
+9,400
| +285% | +$1.7M |
|
4870
CALL
Ashland
ASH
$3.38B
| $2.32M | ﹤0.01% |
28,400
-3,700
| -12% | -$320K |
|
4871
Recursion Pharmaceuticals
RXRX
$1.69B
| $2.32M | ﹤0.01% |
303,090
-434,668
| -59% | -$4.34M |
|
4872
CALL
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
| $2.32M | ﹤0.01% |
44,700
+7,000
| +19% | +$379K |
|
4873
PUT
TD Synnex
SNX
$20.7B
| $2.32M | ﹤0.01% |
23,200
+14,700
| +173% | +$1.45M |
|
4874
CALL
Emcor
EME
$36.9B
| $2.31M | ﹤0.01% |
11,000
+1,800
| +20% | +$377K |
|
4875
CALL
Medifast
MED
$128M
| $2.31M | ﹤0.01% |
30,900
-700
| -2% | -$62.1K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.